Literature DB >> 31599709

Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.

Guang-Hui Li1, Zhong-Hui Ma1,2, Xi Wang1.   

Abstract

Oral squamous cell carcinoma (OSCC) ranks as the sixth most common carcinoma worldwide, and the third most common carcinoma in developing countries as well. Recently, the aberrant expression of lncRNA CCAT1 has been revealed to play an important role in the development of several cancers. However, its role in OSCC remains unknown. The expression levels of CCAT1 and miR-181a were determined in 15 paired primary OSCC tissues and their adjacent noncancerous tissues and cell lines with qPCR. shRNA against CCAT1 was employed to investigate the impact of CCAT1 on proliferation and metastasis. Then dual luciferase reporter and RIP assays were utilized to study the interaction between CCAT1 and miR-181a. Cells transfected with sh-CCAT1 or treated with miR-181a inhibitor were subjected to western blot to investigate the role of Wnt/β-catenin signaling in CCAT1-mediated proliferation and metastasis. Finally, the role of CCAT1 in OSCC was confirmed with tumor xenografts mice model. CCAT1 was upregulated in OSCC tissues and cell lines. Knockdown of CCAT1 inhibited the proliferation, migration and invasion of OSCC cells, while the cell apoptosis was enhanced. Luciferase and RIP assays revealed that miR-181a was a direct target of CCAT1. Inhibition of miR-181a partially reversed the efficacy of sh-CCAT1. Moreover, sh-CCAT1 inhibited OSCC tissues growth through inhibiting Wnt signaling in a miR-181a-dependent manner in vivo. lncRNA CCAT1 activated Wnt/β-catenin signaling via inhibiting miR-181a, resulting in the cell proliferation, migration and invasion of OSCC, suggesting that CCAT1 might serve as a potential target of OSCC treatment. Abbreviation: LncRNA: long non-coding RNA; OSCC: oral squamous cell carcinoma; 3' UTR: 3' untranslated region; ANOVA: one-way analysis of variance; CDK: cyclin-dependent kinase; ceRNA: competing endogenous RNA; FBS: fetal bovine serum; HGF: human gingival fibroblasts; MAPK: mitogen-activated protein kinase; miRNA: micro RNA; ncRNA: noncoding RNAs; PBS: phosphate-buffered saline; PI3K: phosphatidylinositol 3-kinase.

Entities:  

Keywords:  Oral squamous cell carcinoma; Wnt/β-catenin signaling; lncRNA CCAT1; miR-181a

Year:  2019        PMID: 31599709      PMCID: PMC6791703          DOI: 10.1080/15384101.2019.1662257

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  40 in total

1.  Identification of transcription factor-miRNA-lncRNA feed-forward loops in breast cancer subtypes.

Authors:  Leiming Jiang; Xuexin Yu; Xueyan Ma; Haizhou Liu; Shunheng Zhou; Xu Zhou; Qianqian Meng; Lihong Wang; Wei Jiang
Journal:  Comput Biol Chem       Date:  2018-11-16       Impact factor: 2.877

2.  Long non-coding RNA CCAT1/miR-148a/PKCζ prevents cell migration of prostate cancer by altering macrophage polarization.

Authors:  Jie Liu; Degang Ding; Zhaoqiang Jiang; Tao Du; Jianjun Liu; Zhaohui Kong
Journal:  Prostate       Date:  2018-09-16       Impact factor: 4.104

3.  Dickkopf-1 in human oral cancer.

Authors:  Kenji Ogoshi; Atsushi Kasamatsu; Manabu Iyoda; Kentaro Sakuma; Masanobu Yamatoji; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  Int J Oncol       Date:  2011-05-20       Impact factor: 5.650

4.  miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras.

Authors:  Ki-Hyuk Shin; Susan D Bae; Hannah S Hong; Reuben H Kim; Mo K Kang; No-Hee Park
Journal:  Biochem Biophys Res Commun       Date:  2010-12-15       Impact factor: 3.575

Review 5.  Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy.

Authors:  Sankalp A Gharat; Munira Momin; Chintan Bhavsar
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2016       Impact factor: 4.889

Review 6.  The emergence of lncRNAs in cancer biology.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

Review 7.  Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.

Authors:  Larion Santiago; Garrett Daniels; Dongwen Wang; Fang-Ming Deng; Peng Lee
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

8.  C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion.

Authors:  Xiaolu He; Xueming Tan; Xiang Wang; Heiying Jin; Li Liu; Limei Ma; Hong Yu; Zhining Fan
Journal:  Tumour Biol       Date:  2014-09-04

9.  High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis.

Authors:  Hao Bo; Liqing Fan; Jingjing Li; Zhizhong Liu; Shanshan Zhang; Lei Shi; Can Guo; Xiayu Li; Qianjin Liao; Wenling Zhang; Ming Zhou; Bo Xiang; Xiaoling Li; Guiyuan Li; Wei Xiong; Zhaoyang Zeng; Fang Xiong; Zhaojian Gong
Journal:  J Cancer       Date:  2018-11-24       Impact factor: 4.207

10.  Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway.

Authors:  Yong-Tao Yang; Yu-Fan Wang; Ju-Yi Lai; Shi-Yue Shen; Feng Wang; Jie Kong; Wei Zhang; Hong-Yu Yang
Journal:  Cancer Sci       Date:  2016-11-04       Impact factor: 6.716

View more
  13 in total

1.  Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.

Authors:  Hao Feng; Xiaoqi Zhang; Wenli Lai; Jian Wang
Journal:  Cell Cycle       Date:  2020-05-25       Impact factor: 4.534

Review 2.  Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.

Authors:  Anjali P Patni; M K Harishankar; Joel P Joseph; Bhuvanadas Sreeshma; Rama Jayaraj; Arikketh Devi
Journal:  Cell Oncol (Dordr)       Date:  2021-03-11       Impact factor: 6.730

3.  Suppression of circulating AP001429.1 long non-coding RNA in obese patients with breast cancer.

Authors:  Hani Choudhry; Mohammed A Hassan; Abdulrahman L Al-Malki; Kaltoom A Al-Sakkaf
Journal:  Oncol Lett       Date:  2021-05-03       Impact factor: 2.967

4.  Involvement of RUVBL1 in WNT/β-Catenin Signaling in Oral Squamous Cell Carcinoma.

Authors:  Yongfa Zeng; Ying Kong; Lan Liao; Hongshui Zhu
Journal:  Dis Markers       Date:  2022-04-22       Impact factor: 3.464

5.  LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway.

Authors:  Jiandong Li; Xiaohu Xu; Dandan Zhang; Han Lv; Xin Lei
Journal:  Onco Targets Ther       Date:  2021-03-31       Impact factor: 4.147

6.  A Survival-Related Competitive Endogenous RNA Network of Prognostic lncRNAs, miRNAs, and mRNAs in Wilms Tumor.

Authors:  HengChen Liu; MingZhao Zhang; ManYu Shi; TingTing Zhang; ZeNan Zhang; QingBo Cui; ShuLong Yang; ZhaoZhu Li
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

Review 7.  Long Non-Coding RNA (lncRNA) in Oral Squamous Cell Carcinoma: Biological Function and Clinical Application.

Authors:  Jianfei Tang; Xiaodan Fang; Juan Chen; Haixia Zhang; Zhangui Tang
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

8.  MALAT1 promotes liver fibrosis by sponging miR‑181a and activating TLR4‑NF‑κB signaling.

Authors:  Yinghui Wang; Qiuju Mou; Zixin Zhu; Luqiang Zhao; Lili Zhu
Journal:  Int J Mol Med       Date:  2021-10-15       Impact factor: 4.101

Review 9.  Long Non-Coding RNAs as Functional Codes for Oral Cancer: Translational Potential, Progress and Promises.

Authors:  Cing-Syuan Lei; Hsing-Jien Kung; Jing-Wen Shih
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

10.  Long Non-coding RNA Colon Cancer-Associated Transcript-1 Promotes Migration, Invasion, and Epithelial Mesenchymal Transition of Lung Adenocarcinoma by Suppressing miR-219-1.

Authors:  Wenbo Wang; Zhiliang Hou; Chengcai Wen; Liyue Ge; Lili Ge
Journal:  Front Genet       Date:  2020-10-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.